Pfizer compares two pill versions in small Healthy-Volunteer study
NCT ID NCT07117799
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This completed Phase 1 study by Pfizer enrolled 24 healthy adults to compare how two different tablet forms of the drug PF-07248144 are absorbed by the body. Participants received single doses of each form in a crossover design, with some taking the drug after eating. The goal was to measure drug levels in the blood and check for side effects, not to treat any disease.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- PF-07248144
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTHY ADULTS are added.
By submitting, you agree to our Terms of use
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Pfizer Clinical Research Unit - New Haven
New Haven, Connecticut, 06511, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Breakfast or fast? a trial puts Prifetrastat's absorption to the test
- Magic mushroom compound may rewire Self-Awareness — scientists put it to the test
- Can a phone app ease caregiver burnout? new study tests digital therapy
- Robotic hip brace may help control blood sugar after eating
- Smart knee brace and AI could revolutionize home rehab for arthritis
- Training the brain to hear and fix speech errors